Providence Medical Technology Secures $25MM in Equity Financing

Providence Medical Technology closed US $25MM in new equity financing, bringing the total to $53MM raised since 2008. Funds will support market expansion and clinical development of DTRAX® posterior cervical fusion instruments.

In 2Q18, the DTRAX system received FDA 510(k) clearance to be specifically indicated for use in posterior cervical...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us